Novacyt launches two gene COVID-19 test
PARIS: Novacyt S.A, an international specialist in clinical diagnostics, has launched a CE-Mark approved polymerase chain reaction (PCR) two gene target test for COVID-19. The test, which provides an additional option to the Company’s successful single gene test, addresses the…